New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›iShares›WHCA
WHCA

iShares MSCI World Health Care Sector Advanced UCITS ETF

Acc
USD

The WHCA Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: MSCI World Health Care Advanced Select 20 35 Capped Index. The WHCA ETF provides physical exposure, so by buying it you actually own parts of all the 112 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

API
PerformanceDec 31, 2025 - Nov 3, 2026
-5%0%5%10%15%JANMARMAYJULSEPNOV
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
98.91%
Unavailable
0.50%
Other
0.50%
Latest WHCA news

No content available for this fund

FAQ about WHCA

WHCA is a passively managed ETF that invests in the World Health Care segment.
WHCA tracks the MSCI World Health Care Advanced Select 20 35 Capped NR Index - USD, through a full replication replication method.
WHCA carries a total expense ratio (TER) of 0.18%.
WHCA was introduced to the market on November 5, 2021.
iShares MSCI World Health Care Sector Advanced UCITS ETF, WHCA, is provided by iShares. Learn more about iShares here.
Yes, WHCA is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .
WHCA oversees €447M in assets as of November 3, 2026.
WHCA follows a capitalizing, meaning it reinvests income within the fund.
As of September 30, 2026, WHCA has significant geographic allocations in USA, Switzerland and United Kingdom.
As of September 30, 2026, WHCA focuses largely on Healthcare.
As of September 30, 2026, WHCA holds 112 positions in its portfolio, with 55.13% of assets concentrated in its top 15 holdings.
As of September 30, 2026, WHCA top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of WHCA is USD.
Data as of 09/30/26
Eli Lilly & Co.
10.75%
Johnson & Johnson
6.18%
AbbVie, Inc.
5.70%
Novartis AG
5.04%
Merck & Co., Inc.
3.75%
Roche Holding AG
3.56%
UnitedHealth Group, Inc.
3.55%
AstraZeneca PLC
2.82%
Gilead Sciences, Inc.
2.63%
Amgen, Inc.
2.37%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight